Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.32 |
| ▸ | CA4 known ✓ | P22748 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.31 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2937133 | 1.00 | CYP3A4 (0.33) | CYP3A4CA2TDP1CA4RECQL | |
| Ethylene SCHEMBL25418134 | 0.98 | CYP3A4 (0.32) | CYP3A4CA2TDP1CA4RECQL | |
| Potassium Ion SCHEMBL11909775 | 0.97 | CYP3A4 (0.33) | CYP3A4TDP1RECQLTSHRMAPT | |
| SCHEMBL6418327 | 0.97 | CYP3A4 (0.33) | CYP3A4TDP1RECQLTSHRMAPT | |
| Ethylene Glycol SCHEMBL20135732 | 0.95 | CYP3A4 (0.30) | CYP3A4 | |
| SCHEMBL2937130 | 0.88 | CYP3A4 (0.32) | CYP3A4CA2TDP1CA4TSHR | |
| Phenol SCHEMBL1777269 | 0.86 | CYP3A4 (0.40) | CYP3A4TSHR | |
| SCHEMBL1081592 | 0.86 | — | — | |
| SCHEMBL1629058 | 0.83 | CA4 (0.33) | CA2CA4 | |
| SCHEMBL87407 | 0.82 | CASP1 (0.36) | CYP3A4TDP1RECQLTSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 758 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11802369-B2 | Laminated light-blocking decorative articles | EASTMAN KODAK COMPANY (US) | 2023-10-31 | — | — | US | claimed |
| US-20230304217-A1 | LAMINATE PRECURSOR ROLLS AND LAMINATED DECORATIVE ARTICLES | EASTMAN KODAK COMPANY | 2023-09-28 | — | — | US | claimed |
| US-11746463-B2 | Method for preparing laminated precursor rolls | EASTMAN KODAK COMPANY (US) | 2023-09-05 | — | — | US | claimed |
| US-20230232829-A1 | HIGH-LOAD HALOXYFOP ESTER COMPOSITIONS | CORTEVA AGRISCIENCE LLC | 2023-07-27 | — | — | US | claimed |
| CN-116375396-A | Self-cleaning rock slice real stone paint and preparation method thereof | 天津德普威涂料有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-116215027-A | Novel vegetable film and preparation process thereof | 山东亚新塑料包装有限公司 | 2023-06-06 | — | — | CN | claimed |
| CN-116217776-A | Water-based acrylic emulsion for mesh fabric and preparation method thereof | 上海保立佳新材料有限公司 | 2023-06-06 | — | — | CN | claimed |
| CN-112708954-B | Rose plant extract cellulose fiber and preparation method thereof | 青岛邦特生态纺织科技有限公司 | 2023-02-17 | — | — | CN | claimed |
| CN-115612498-A | Eluting agent for eluting petroleum-polluted soil and eluting method | 中国石油化工股份有限公司 | 2023-01-17 | — | — | CN | claimed |
| US-11549213-B2 | Method for making laminated light-blocking decorative article | EASTMAN KODAK COMPANY (US) | 2023-01-10 | — | — | US | claimed |
| WO-1992022613-A1 | OZONE-FRIENDLY CORRECTION FLUID | THE GILLETTE COMPANY (US) | 1992-12-23 | — | — | WO | claimed |
| EP-0079836-B1 | COMPOSITIONS BASED ON WATER-SOLUBLE GUMS, THEIR PREPARATION AND THEIR USE | RHONE-POULENC CHIMIE (FR) | 1987-01-21 | — | — | EP | claimed |
| EP-0079837-B1 | COMPOSITIONS BASED ON WATER-SOLUBLE GUMS, THEIR PREPARATION AND USE | RHONE-POULENC CHIMIE (FR) | 1987-01-21 | — | — | EP | claimed |
| EP-0080879-B1 | PHARMACEUTICAL COMPOSITION CONTAINING INTERFERON IN STABLE STATE | SUNSTAR KABUSHIKI KAISHA (JP) | 1986-10-01 | — | — | EP | claimed |
| US-4605555-A | INTERFERON, POLYHYDRIC SUGAR ALCOHOL, ORGANIC ACID BUFFER | SUN STAR KABUSHIKI KAISHA (JP) | 1986-08-12 | — | — | US | claimed |
| US-4605556-A | APPLYING INTERFERON, POLYHYDRIC SUGAR ALCOHOL, AND ORGANIC ACID BUFFER | SUN STAR KABUSHIKI KAISHA (JP) | 1986-08-12 | — | — | US | claimed |
| EP-0080879-A2 | Pharmaceutical composition containing interferon in stable state | SUNSTAR KABUSHIKI KAISHA (JP) | 1983-06-08 | — | — | EP | claimed |
| US-4171958-A | PORPHYRIN COMPOUND AND A METAL ALKYL SULFOSUCCINATE | PHILLIPS PETROLEUM COMPANY (US) | 1979-10-23 | — | — | US | claimed |
| US-4127383-A | LIGNOSULFONATE | GRAHAM-WHITE SALES CORPORATION (US) | 1978-11-28 | — | — | US | claimed |
| US-4068054-A | PORPHYRIN COMPOUND | PHILLIPS PETROLEUM COMPANY (US) | 1978-01-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230232829-A1 | HIGH-LOAD HALOXYFOP ESTER COMPOSITIONS | HDHD5, LIPA, CETP | CA2 2298/4885CA4 2327/4885CYP3A4 2694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.